Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

Written by ClinicalTrials.gov

Category: Joint Diseases

Published: 30 July 2013

Condition: Rheumatoid Arthritis
Interventions: Drug: Tofacitinib (Xeljanz); Drug: Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc
Sponsors: Pfizer; Pfizer
Enrolling by invitation - verified August 2013

Details: Last Updated: 30 July 2013

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies